Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13 ...

Recursion Pharmaceuticals has reported updated data from its ELUCIDATE & TUPELO trials, but the stock has failed to mount a ...

Deep dive into RBAC vs ReBAC for enterprise sso. Learn which authorization model fits your ciam strategy and how to avoid role explosion in complex apps.

As the free online encyclopedia turns 25, it’s facing political opposition, AI scraping, dwindling volunteers, and a public ...

Unfolding like 100 years of home video footage that were shot by the family ghosts, Mascha Schilinski’s rich and mesmeric “ ...

Information pervades the universe, yet means nothing. Meaning emerged when matter organized into systems that could ...

Gordon died in a hotel room with a copy of his favorite children’s book, Goodnight Moon, at his side. Inside, he left ...

Smith turns out to be responsible for a number of Affleck/Damon crossovers: Damon has tiny roles in the Affleck starrers Chasing Amy and Jersey Girl, and they spoof themselves in Jay and Silent Bob ...

Noetik CEO and co-founder Ron Alfa, M.D., Ph.D., said the licensing of human foundation models is “a new paradigm in biotech.” With the GSK deal validating the paradigm, in Alfa’s view, Noetik ...

Machine learning is reshaping the way portfolios are built, monitored, and adjusted. Investors are no longer limited to ...

Gerald Murnane’s Landscape with Landscape opens with a splendidly disgruntled preface. The book is a collection of six ...

Broadcom enters 2026 at an inflection point, with strong tailwinds from its ASIC and Networking segments. Read why AVGO stock is a Buy.